MERTK and breast cancer: Interestingly, MerTK-/- leukocytes reduced tumor growth and expressed lower levels of anti-inflammatory cytokines such as IL-10, but higher levels of pro-inflammatory IL-6 and IL1-β in mammary cancer cells [94].